Most lung cancers are non-small cell lung cancers (NSCLC), and adenocarcinoma is the most common subtype with an increasing trend in relative incidence [2] .
← all excerpts
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis.
1
—
—